WGS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
WGS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). GeneDx Holdings's share price for the quarter that ended in Dec. 2023 was $2.75. GeneDx Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 26.0 Mil. Therefore, GeneDx Holdings's market cap for the quarter that ended in Dec. 2023 was $71.4 Mil.
GeneDx Holdings's quarterly market cap declined from Jun. 2023 ($153.5 Mil) to Sep. 2023 ($94.2 Mil) and declined from Sep. 2023 ($94.2 Mil) to Dec. 2023 ($71.4 Mil).
GeneDx Holdings's annual market cap declined from Dec. 2021 ($1,082.2 Mil) to Dec. 2022 ($102.5 Mil) and declined from Dec. 2022 ($102.5 Mil) to Dec. 2023 ($71.4 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. GeneDx Holdings's Enterprise Value for Today is $278.3 Mil.
The historical data trend for GeneDx Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GeneDx Holdings Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Market Cap | - | - | 1,082.21 | 102.49 | 71.44 |
GeneDx Holdings Quarterly Data | |||||||||||||||
Dec19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Market Cap | Get a 7-Day Free Trial | 102.49 | 291.41 | 153.54 | 94.19 | 71.44 |
For the Health Information Services subindustry, GeneDx Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, GeneDx Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where GeneDx Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
GeneDx Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
Market Cap (A: Dec. 2023 ) | = | Share Price (A: Dec. 2023 ) | * | Shares Outstanding (EOP) (A: Dec. 2023 ) |
= | $2.75 | * | 25.9789 | |
= | $71.4 |
GeneDx Holdings's Market Cap for the quarter that ended in Dec. 2023 is calculated as
Market Cap (Q: Dec. 2023 ) | = | Share Price (Q: Dec. 2023 ) | * | Shares Outstanding (EOP) (Q: Dec. 2023 ) |
= | $2.75 | * | 25.9789 | |
= | $71.4 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GeneDx Holdings (NAS:WGS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Thank you for viewing the detailed overview of GeneDx Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Kareem Saad | officer: Chief Business Officer | C/O SEMA4 HOLDINGS CORP, 333 LUDLOW STREET, NORTH TOWER, 8TH FL., STAMFORD CT 06902 |
Katherine Stueland | director, officer: Chief Executive Officer | 458 BRANNAN STREET, SAN FRANCISCO CA 94107 |
Kevin Feeley | officer: Chief Financial Officer | C/O SEMA4 HOLDINGS CORP, 333 LUDLOW STREET, NORTH TOWER, 8TH FL., STAMFORD CT 06902 |
Jason Ryan | director | C/O FOUNDATION MEDICINE, INC., ONE KENDALL SQUARE, SUITE B3501, CAMBRIDGE MA 02139 |
Keith A. Meister | director, 10 percent owner | C/O ICAHN CAPITAL LP, 767 FIFTH AVENUE, SUITE 4700, NEW YORK NY 10153 |
Pfenniger Richard C Jr | director | 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Karen Ann White | officer: Chief People Officer | C/O SEMA4 HOLDINGS CORP, 333 LUDLOW STREET, NORTH TOWER, 8TH FL., STAMFORD CT 06902 |
Casdin Partners Fo1-msv, Lp | director, 10 percent owner | C/O CASDIN PARTNERS GP, LLC, 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019 |
Casdin Partners Master Fund, L.p. | director, 10 percent owner | WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001 |
Eli Casdin | director, 10 percent owner | 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019 |
Casdin Capital, Llc | director, 10 percent owner | 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019 |
Casdin Partners Gp, Llc | director, 10 percent owner | 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019 |
Icahn School Of Medicine At Mount Sinai | 10 percent owner | 1 GUSTAVE L. LEVY PLACE, NEW YORK NY 10029 |
Corvex Management Lp | director, 10 percent owner | 667 MADISON AVENUE, NEW YORK NY 10065 |
Opko Health, Inc. | 10 percent owner | 4400 BISCAYNE BLVD., MIAMI FL 33137 |
From GuruFocus
By Marketwired • 07-18-2023
By Marketwired • 06-26-2023
By sperokesalga sperokesalga • 05-04-2023
By GuruFocus Research • 10-30-2023
By Marketwired • 09-06-2023
By Marketwired • 08-21-2023
By Marketwired • 08-09-2023
By Marketwired • 08-07-2023
By sperokesalga sperokesalga • 04-18-2023
By GuruFocus Research GuruFocus Editor • 05-20-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.